HIV Nanomedicine

Podcast: HIV Nanomedicine

According to recent numbers released by UNAIDS, up to 42.9 million people are living with HIV, but only 19.5 million people around the world have access to antiretroviral therapy.

Pioneering collaborative interdisciplinary research projects led by the University of Liverpool aims to reduce this gap through the use of nanotechnology.

Listen to Steve Rannard, Professor of Chemistry in the Faculty of Science and Engineering, and Andrew Owen, Professor of Molecular and Clinical Pharmacology in the Faculty of Health and Life Sciences, discuss their research in our podcast.

Together they have been leading the development of a new nanomedicine for HIV patients using Solid Drug Nanoparticle technology.